Pangaea Oncology boosts growth through small acquisitions in private healthcare. Take advantage of more personalized and less toxic drugs based on the genetic profiles of each patient.
We are pleased to share the success story of Anisha Jain, a PhD student from the JSS Medical Research, India. Thanks to EACR Travel Fellowship, join us at Instituto Oncológico Dr. Rosell.
The decision whether or not to add HIPEC to surgery in ovarian cancer recurrence is clear: intraoperative chemotherapy increases survival without added toxicity.